Publication: Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency
Issued Date
2000-12-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-0034570627
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.31, No.4 (2000), 795-800
Suggested Citation
Suthida Kankirawatana, Chularatana Mahasandana, Gavivann Veerakul, Julin Seeloem, Lerlugsn Suwantol, Voravan Tanphaichitr, Vinai Suvatte Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.31, No.4 (2000), 795-800. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26085
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency
Other Contributor(s)
Abstract
During the period 1984-1992. 2 severe cases (1 male, 1 female) of congenital F VII deficiency with intracranial hemorrhage (ICH) were referred to the Department of Pediatrics, Siriraj Hospital Bangkok, Thailand at the ages of 1 and 3 months old. They both responded very well to fresh frozen plasma (FFP) transfusion therapy. Subsequently, both had repeated episodes of ICH (repeated ICH) 5 and 6 times, despite the 10-14 days of replacement therapy for each episode and eventually died at the ages of 11 and 13 months. Since September 1996, another 2 severe cases (2 females) of congenital F VII deficiency who had ICH within their first month of life were referred to us. In order to prevent repeated ICH, we started a prophylactic regime after the second episode of ICH, by giving FFP 10 ml/kg twice a week. The average duration of follow up was 21 months (at 8 and 34 months). All of them (aged 14, and 38 months old) are doing well at this time and free from repeated ICH. From this observation, if there is FFP available, this regime is an effective way to prevent repeated ICH in infants with severe congenital Factor VII deficiency.